Stock 6808 3D GLOBAL BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials 3D Global Biotech Inc.

Equities

6808

TW0006808009

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
33.75 TWD +0.15% Intraday chart for 3D Global Biotech Inc. +11.02% +73.52%
Apr. 19 3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 2,645 2,143 1,498 1,088
Enterprise Value (EV) 1 2,389 1,931 1,306 932.6
P/E ratio -54.8 x -35.9 x -22 x -18.9 x
Yield - - - -
Capitalization / Revenue 199 x 193 x 110 x 52.7 x
EV / Revenue 180 x 174 x 95.7 x 45.2 x
EV / EBITDA -78.5 x -45.5 x -27.7 x -23.3 x
EV / FCF -389 x -114 x -102 x -72 x
FCF Yield -0.26% -0.88% -0.98% -1.39%
Price to Book 5.89 x 5.5 x 4.41 x 3.75 x
Nbr of stocks (in thousands) 53,970 53,970 55,580 55,950
Reference price 2 49.00 39.70 26.95 19.45
Announcement Date 3/12/21 3/24/22 3/25/23 4/19/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 11.85 18.18 13.26 11.08 13.64 20.63
EBITDA 1 -34.73 -25.02 -30.41 -42.46 -47.15 -39.96
EBIT 1 -42.06 -36.3 -50.33 -62.21 -66.29 -62.85
Operating Margin -354.92% -199.73% -379.52% -561.71% -485.87% -304.62%
Earnings before Tax (EBT) 1 -39.75 -33.75 -48.48 -60.97 -83.13 -58.92
Net income 1 -39.75 -36.32 -47.92 -59.7 -67.09 -57.95
Net margin -335.4% -199.79% -361.35% -539.1% -491.72% -280.87%
EPS 2 -0.8000 -0.7200 -0.8947 -1.106 -1.222 -1.030
Free Cash Flow 1 -20.51 -6.916 -6.137 -16.98 -12.85 -12.95
FCF margin -173.01% -38.05% -46.28% -153.32% -94.22% -62.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/10/20 12/10/20 3/12/21 3/24/22 3/25/23 4/19/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 182 287 256 212 192 156
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -20.5 -6.92 -6.14 -17 -12.9 -13
ROE (net income / shareholders' equity) -9.59% -8.22% -10.2% -14.2% -18.4% -18.3%
ROA (Net income/ Total Assets) -6.16% -4.97% -6.36% -8.57% -10.4% -11.3%
Assets 1 644.8 731.4 753.1 696.5 644.3 512.9
Book Value Per Share 2 7.310 9.060 8.320 7.220 6.110 5.180
Cash Flow per Share 2 0.3800 0.1600 0.1600 0.3800 0.2800 0.3900
Capex 1 1.54 0.04 0.03 2.86 0.85 0.78
Capex / Sales 13.02% 0.19% 0.23% 25.85% 6.19% 3.77%
Announcement Date 12/10/20 12/10/20 3/12/21 3/24/22 3/25/23 4/19/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
3D GLOBAL BIOTECH INC. Stock 3D Global Biotech Inc.
+73.52% 68.06M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.77% 184B
MEDTRONIC PLC Stock Medtronic plc
-1.77% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.43% 69.44B
DEXCOM, INC. Stock DexCom, Inc.
+2.06% 50.37B
CENCORA, INC. Stock Cencora, Inc.
+9.43% 44.82B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.53B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.04% 26.73B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+4.64% 26.84B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.71B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6808 Stock
  4. Financials 3D Global Biotech Inc.